加速器制备医用放射性同位素的现状与展望

The Current Situation and Prospect of Accelerator Produced Medical Radioisotopes

加速器制备核素以其独特的自身优势成为制备放射性同位素的重要方式之一,在进入新世纪后作用与地位日益突出。本文对国内外加速器制备医用放射同位素技术的发展现状进行了简要概述,着重分析了^(18) F、^(64)Cu、^(68)Ge/^(68)Ga、^(89)Zr、^(111)In、^(211)At、^(225)Ac等重要医用放射性核素研究进展,并对我国加速器制备医用同位素的应用前景进行了展望。

As one of the important ways to prepare radioisotopes,the role and status of accelerator produced nuclides have become increasingly prominent after entering the new century.In the present paper,a brief overview on development status of radioisotope preparation technology by accelerators at home and abroad was performed.In particular,the research progress of ^(18)F,^(64)Cu,^(68)Ge/^(68)Ga,^(89)Zr,^(111)In,^(211)At,^(225)Ac and other important medical radioisotope preparation technologies are introduced.The application prospects of isotopes prepared by domestic accelerators are also prospected.